Joe Oliverio, president of Positron, said: “We are grateful to the University of Texas Health Science Center at Houston and Dr Gould for selecting Positron as the exclusive licensee of their heart disease management product.
“The market is void of such a product and will position Positron to be able to offer a total cardiac solution to customers reaching well beyond the sale to physicians.”